Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

The average for the healthcare industry is 18 ... Semaglutide has been on the market since 2017, and it is the active ...

Research suggests it's even more effective than semaglutide, marketed as Wegovy for weight loss and Ozempic for diabetes, enabling non-diabetic people to lose between 15 to 20% of their body weight on ...

“In general, for children who are malnourished and failing to thrive, nutritional supplementation with specific nutrients that are absent can impact their growth — height and weight gain,” Dr. Krupa ...

Pharmacy spend is becoming a key value lever at US portfolio companies as PE firms up their focus on healthcare oversight, ...